fluconazole and Colorectal Cancer

fluconazole has been researched along with Colorectal Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Cheng, J; Dong, G; Li, Y; Sheng, C; Wang, X	1
Bastiaens, PIH; Harizanova, J; Klein, CH; Martín-Gago, P; Murarka, S; Truxius, DC; Vogel, HA	1

Other Studies

2 other study(ies) available for fluconazole and Colorectal Cancer

Article	Year
Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer. Journal of medicinal chemistry, 2020, 07-23, Volume: 63, Issue:14 Topics: Animals; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Cyclic Nucleotide Phosphodiesterases, Type 6; Drug Design; Female; Humans; Male; Mice, Inbred BALB C; Molecular Structure; Mutation; Phosphodiesterase Inhibitors; Proteolysis; Proto-Oncogene Proteins p21(ras); Pyrazoles; Pyridazines; Rats, Sprague-Dawley; Structure-Activity Relationship; Ubiquitin-Protein Ligases	2020
PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas. International journal of cancer, 2019, 02-15, Volume: 144, Issue:4 Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclic Nucleotide Phosphodiesterases, Type 6; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Mutation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); RNA Interference	2019

Article

Year

Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer.

Journal of medicinal chemistry, 2020, 07-23, Volume: 63, Issue:14

Topics: Animals; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Cyclic Nucleotide Phosphodiesterases, Type 6; Drug Design; Female; Humans; Male; Mice, Inbred BALB C; Molecular Structure; Mutation; Phosphodiesterase Inhibitors; Proteolysis; Proto-Oncogene Proteins p21(ras); Pyrazoles; Pyridazines; Rats, Sprague-Dawley; Structure-Activity Relationship; Ubiquitin-Protein Ligases

2020

PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas.

International journal of cancer, 2019, 02-15, Volume: 144, Issue:4

Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclic Nucleotide Phosphodiesterases, Type 6; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Mutation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); RNA Interference

2019